Similar effects of pulse corticosteroid and tumor necrosis factor a blockade in rheumatoid arthritis: Reply

Similar effects of pulse corticosteroid and tumor necrosis factor a blockade in rheumatoid arthritis: Reply

Bibliographic Details
Main Authors:	Taylor, P, Paleolog, E, Maini, R
Format:	Journal article
Published:	2001

Similar Items

Similarities in the mechanisms of action of pulse corticosteroids and anti-tumor necrosis factor alpha therapy in rheumatoid arthritis - Reply
by: Maini, R, et al.
Published: (1998)

Reduction of chemokine levels and leukocyte traffic to joints by tumor necrosis factor alpha blockade in patients with rheumatoid arthritis.
by: Taylor, P, et al.
Published: (2000)

Anti-tumor necrosis factor alpha therapy of rheumatoid arthritis. Mechanism of action.
by: Feldmann, M, et al.
Published: (1997)

Deactivation of vascular endothelium by monoclonal anti-tumor necrosis factor alpha antibody in rheumatoid arthritis.
by: Paleolog, E, et al.
Published: (1996)

Modulation of angiogenic vascular endothelial growth factor by tumor necrosis factor alpha and interleukin-1 in rheumatoid arthritis.
by: Paleolog, E, et al.
Published: (1998)

Beneficial effects of tumour necrosis factor-alpha (TNF-alpha) blockade in rheumatoid arthritis (RA)
by: Maini, R, et al.
Published: (1995)

Cytokine blockade in rheumatoid arthritis.
by: Feldmann, M, et al.
Published: (2001)

Anaemia of chronic disease in rheumatoid arthritis: in vivo effects of tumour necrosis factor alpha blockade.
by: Davis, D, et al.
Published: (1997)

Anti-tumour necrosis factor specific antibody (infliximab) treatment provides insights into the pathophysiology of rheumatoid arthritis.
by: Maini, R, et al.
Published: (1999)

Anti-tumor necrosis factor-alpha therapy of rheumatoid arthritis.
by: Feldmann, M, et al.
Published: (1997)

Use of anti-tumor necrosis factor antibodies in rheumatoid arthritis.
by: Feldmann, M, et al.
Published: (1994)

Systemic anti-tumor necrosis factor alpha therapy in rheumatoid arthritis down-regulates synovial tumor necrosis factor alpha synthesis.
by: Ulfgren, A, et al.
Published: (2000)

Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha.
by: Elliot, M, et al.
Published: (2008)

Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha.
by: Elliott, M, et al.
Published: (1993)

Tumor necrosis factor-α blockade treatment decreased CD154 (CD40-ligand) expression in rheumatoid arthritis.
by: Chien-Hsueh Tung, et al.
Published: (2017-01-01)

Selective immunosuppression of tumour necrosis factor-alpha in rheumatoid arthritis.
by: Brennan, F, et al.
Published: (1995)

Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group.
by: Lipsky, P, et al.
Published: (2000)

Corticosteroids in rheumatoid arthritis.
by: Dennison, E, et al.
Published: (1998)

Expression of granulocyte-macrophage colony-stimulating factor in rheumatoid arthritis: regulation by tumor necrosis factor-alpha.
by: Haworth, C, et al.
Published: (1991)

Localization of tumor necrosis factor alpha in synovial tissues and at the cartilage-pannus junction in patients with rheumatoid arthritis.
by: Chu, C, et al.
Published: (1991)

Localization of tumor necrosis factor receptors in the synovial tissue and cartilage-pannus junction in patients with rheumatoid arthritis. Implications for local actions of tumor necrosis factor alpha.
by: Deleuran, B, et al.
Published: (1992)

Decrease in cellularity and expression of adhesion molecules by anti-tumor necrosis factor alpha monoclonal antibody treatment in patients with rheumatoid arthritis.
by: Tak, P, et al.
Published: (1996)

INCREASED EXPRESSION OF TUMOR-NECROSIS-FACTOR RECEPTORS ON CELLS ISOLATED FROM RHEUMATOID-ARTHRITIS SYNOVIAL JOINTS
by: Gibbons, D, et al.
Published: (1992)

TNF blockade in rheumatoid arthritis: implications for therapy and pathogenesis.
by: Maini, R, et al.
Published: (1997)

Interference of tumor necrosis factor inhibitor treatments on soluble tumor necrosis factor receptor 2 levels in rheumatoid arthritis
by: Nicole Yang, et al.
Published: (2019-08-01)

The tumor necrosis factor-α inhibitor golimumab in the treatment of rheumatoid arthritis
by: Natalia Vladimirovna Chichasova
Published: (2014-12-01)

Study on Tumor Necrosis Factor-α· Gene Polymorphism in Rheumatoid Arthritis
by: Kim Kyung-Un, et al.
Published: (2007-06-01)

Immunological intervention reveals reciprocal roles for tumor necrosis factor-alpha and interleukin-10 in rheumatoid arthritis and systemic lupus erythematosus.
by: Maini, R, et al.
Published: (1994)

Effects of treatment of rheumatoid arthritis patients with an antibody against tumour necrosis factor alpha on reticuloendothelial and intrapulmonary granulocyte traffic.
by: Taylor, P, et al.
Published: (1999)

Angiogenesis in rheumatoid arthritis.
by: Paleolog, E
Published: (2002)

Selective blockade of tumor necrosis factor receptor I inhibits proinflammatory cytokine and chemokine production in human rheumatoid arthritis synovial membrane cell cultures.
by: Schmidt, E, et al.
Published: (2013)

Evidence that rheumatoid arthritis synovial T cells are similar to cytokine-activated T cells: involvement of phosphatidylinositol 3-kinase and nuclear factor kappaB pathways in tumor necrosis factor alpha production in rheumatoid arthritis.
by: Brennan, F, et al.
Published: (2002)

USE OF TUMOR NECROSIS FACTOR-A INHIBITORS IN RHEUMATOID ARTHRITIS: TOPICAL ASPECTS
by: E L Luchikhina, et al.
Published: (2008-12-01)

Comparison of drug survival rates for tumor necrosis factor antagonists in rheumatoid arthritis
by: Mart&iacute;nez-Santana V, et al.
Published: (2013-07-01)

USE OF TUMOR NECROSIS FACTOR-A INHIBITORS IN RHEUMATOID ARTHRITIS: TOPICAL ASPECTS
by: E L Luchikhina, et al.
Published: (2008-12-01)

Predictors of tumor necrosis factor inhibitors primary failure in rheumatoid arthritis patients
by: Amira Mohamed Khafagi, et al.
Published: (2024-05-01)

TNFα blockade in rheumatoid arthritis: Rationale, clinical outcomes and mechanisms of action
by: Elliott, M, et al.
Published: (1995)

TNF alpha blockade in rheumatoid arthritis: rationale, clinical outcomes and mechanisms of action.
by: Elliott, M, et al.
Published: (1995)

Selective tumor necrosis factor receptor I blockade is antiinflammatory and reveals immunoregulatory role of tumor necrosis factor receptor II in collagen-induced arthritis.
by: McCann, F, et al.
Published: (2014)

Insights into the pathogenesis of rheumatoid arthritis from application of anti-TNF therapy.
by: Maini, R, et al.
Published: (2000)